Leukocyte telomere length: a potential biomarker for the prognosis of coronary artery disease

Biomark Med. 2020 Jul;14(11):933-941. doi: 10.2217/bmm-2020-0171. Epub 2020 Jul 2.

Abstract

Aim: This study aimed to explore the prognostic value of leukocyte telomere length (LTL) in patients with coronary artery disease (CAD). Materials & methods: We enrolled 366 CAD patients and 76 healthy subjects in this study. LTL was measured. All subjects were followed up for 6 months for further analysis regarding major adverse cardiac events (MACEs). Results: CAD patients had a significantly shortened LTL compared with healthy subjects (p < 0.05). The area under the curve for LTL prediction of MACEs was 0.769 (p < 0.001), with a shorter LTL being an independent predictor of MACEs (Cox proportional hazards regression, hazard ratio: 2.866; p < 0.001). Conclusion: LTL could be considered as an independent predictor of short-term MACEs in CAD.

Keywords: biomarker; coronary artery disease; leukocyte telomere length; prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / metabolism
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / genetics*
  • Female
  • Humans
  • Leukocytes / metabolism*
  • Male
  • Middle Aged
  • Prognosis
  • Risk Factors
  • Telomere / genetics*

Substances

  • Biomarkers